当前位置: 首页 > 详情页

Activation of the phosphatidylinositol 3-kinase/Akt pathway is involved in lipocalin-2-promoted human pulmonary artery smooth muscle cell proliferation

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Beijing Childrens Hosp, Key Lab Major Dis Children, Minist Educ, Beijing 100045, Peoples R China; [2]Capital Med Univ, Immunol Lab, Beijing Pediat Res Inst, Beijing Childrens Hosp, Beijing 100045, Peoples R China; [3]Chinese Acad Med Sci, State Key Lab Cardiovasc Dis, Fuwai Hosp, Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China; [4]Peking Union Med Coll, Beijing 100021, Peoples R China
出处:
ISSN:

关键词: Proliferation Akt Phosphorylation Lipocalin-2 (Lcn2) Pulmonary hypertension (PH)

摘要:
Over-activated PI3K/Akt signaling, a pathway strongly related to cancer survival and proliferation, has been reported recently to be involved in pulmonary artery smooth muscle cell apoptosis and proliferation in pulmonary hypertension (PH). In this study, we observed greatly increased lipocalin-2 (Lcn2) expression accompanied with over-activated PI3K/Akt signaling in a standard rat model of PH induced by monocrotaline. In view of the close relationship between Lcn2 and PI3K/Akt pathway, we hypothesized that the up-regulated Lcn2 might be a trigger of over-activated PI3K/Akt signaling in PH. Our results showed that Lcn2 significantly activated the PI3K/Akt pathway (determined by augmented Akt phosphorylation and up-regulated Mdm2) and significantly promoted proliferation (assessed by Ki67 staining) in cultured human pulmonary artery smooth muscle cells. Furthermore, we demonstrated that inhibition of Akt phosphorylation (LY294002) abrogated the Lcn2-promoted proliferation in cultured human pulmonary artery smooth muscle cells. In conclusion, Lcn2 significantly promoted human pulmonary artery smooth muscle cell proliferation by activating PI3K/Akt pathway. Further study on the role and mechanism of Lcn2 will help explore novel therapeutic strategies based on attenuating over-activated PI3K/Akt signaling in PH.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2014]版:
大类 | 4 区 生物
小类 | 4 区 细胞生物学
最新[2023]版:
大类 | 2 区 生物学
小类 | 3 区 细胞生物学
JCR分区:
出版当年[2013]版:
Q3 CELL BIOLOGY
最新[2023]版:
Q3 CELL BIOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2013版] 出版当年五年平均 出版前一年[2012版] 出版后一年[2014版]

第一作者:
第一作者机构: [1]Capital Med Univ, Beijing Childrens Hosp, Key Lab Major Dis Children, Minist Educ, Beijing 100045, Peoples R China; [2]Capital Med Univ, Immunol Lab, Beijing Pediat Res Inst, Beijing Childrens Hosp, Beijing 100045, Peoples R China; [3]Chinese Acad Med Sci, State Key Lab Cardiovasc Dis, Fuwai Hosp, Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China; [4]Peking Union Med Coll, Beijing 100021, Peoples R China
通讯作者:
通讯机构: [1]Capital Med Univ, Beijing Childrens Hosp, Key Lab Major Dis Children, Minist Educ, Beijing 100045, Peoples R China; [2]Capital Med Univ, Immunol Lab, Beijing Pediat Res Inst, Beijing Childrens Hosp, Beijing 100045, Peoples R China;
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院